NALIRIFOX in first-line therapy for metastatic pancreatic adenocarcinoma

被引：0
|
作者：
Anglaret, Siriane [1 ]
Hilmi, Marc [2 ]
机构：
[1] Gustave Roussy, Dept Med Oncol, Villejuif, France
[2] Inst Curie, Dept Oncol Med, St Cloud, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 11期
关键词：
Pancreatic ductal adenocarcinoma; Metastatic; NALIRIFOX; IRINOTECAN; CANCER;
D O I：
10.1016/j.bulcan.2024.06.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：999 / 1000
页数：2
相关论文
共 50 条
  • [1] Updates on First-Line Therapy for Metastatic Pancreatic Adenocarcinoma
    Marks, Eric
    Saif, Muhammad Wasif
    Jia, Yuxia
    JOURNAL OF THE PANCREAS, 2014, 15 (02): : 99 - 102
  • [2] Metastatic pancreatic cancer. Survival benefit through new first-line therapy with NALIRIFOX
    Pickl, Susanne
    VISCERAL MEDICINE, 2024, 40 (04)
  • [3] Liposomal Irinotecan: A Review as First-Line Therapy in Metastatic Pancreatic Adenocarcinoma
    Brown, Michael B.
    Blair, Hannah A.
    DRUGS, 2025, 85 (02) : 255 - 262
  • [4] Updates on First-Line Treatment of Metastatic Pancreatic Adenocarcinoma
    Strimpakos, Alexios S.
    Syrigos, Kostas N.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2011, 12 (04): : 339 - 342
  • [5] NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
    Nichetti, Federico
    Rota, Simone
    Ambrosini, Paolo
    Pircher, Chiara
    Gusmaroli, Eleonora
    Busset, Michele Droz Dit
    Pusceddu, Sara
    Sposito, Carlo
    Coppa, Jorgelina
    Morano, Federica
    Pietrantonio, Filippo
    Di Bartolomeo, Maria
    Mariani, Luigi
    Mazzaferro, Vincenzo
    de Braud, Filippo
    Niger, Monica
    JAMA NETWORK OPEN, 2024, 7 (01)
  • [6] Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus
    Malla, Midhun
    Fuqua, Jacob
    Mukherjee, Sarbajit
    Goldberg, Richard M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (12) : 1748 - 1760
  • [7] Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus
    Midhun Malla
    Jacob Fuqua
    Sarbajit Mukherjee
    Richard M. Goldberg
    Current Treatment Options in Oncology, 2022, 23 : 1748 - 1760
  • [8] Cost-effectiveness of NALIRIFOX compared to other first-line treatments for metastatic pancreatic cancer.
    Tan, Chia Jie
    Liu, Haopeng
    Farrokhi, Pegah
    Garrido-Laguna, Ignacio
    Stenehjem, David D.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [9] NALIRIFOX for metastatic pancreatic adenocarcinoma: hope or hype?
    Nevala-Plagemann, Christopher
    Garrido-Laguna, Ignacio
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (08) : 567 - 568
  • [10] First-Line Treatment of Metastatic Pancreatic Adenocarcinoma: Can We Do Better?
    Merl, Man Yee
    Abdelghany, Osama
    Li, Jia
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (04): : 317 - 320
12345